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CI, 1.01 to 1.09) and a 10 mm Hg rise in systolic blood pressure,Mortality and technique failure in patients starting chronic
with a RR of 1.42 (95% CI, 1.17 to 1.73). The removal of 1peritoneal dialysis: Results of the Netherlands Cooperative
mmol/week/1.73 m2 of urinary and dialysate creatinine wasStudy on the Adequacy of Dialysis.
associated with a RR of death of 0.95 (95% CI, 0.92 to 0.98)Background. Recent studies have shown an association be-
and 0.93 (95% CI, 0.89 to 0.98). The removal of urea had atween small solute clearance and patient survival. Thus far,
similar association with the RR of death. Predictors for tech-little attention has been paid to the potential effects of fluid
nique failure were urine volume, peritoneal ultrafiltration, andoverload. The aim of this study was to determine the relative
systolic blood pressure.importance of baseline patient and treatment characteristics
Conclusions. Dialysate solute removal was an independentto mortality and technique failure in patients starting peritoneal
predictor of mortality. The association between systolic blooddialysis.
Methods. One hundred and eighteen consecutive new pa- pressure and mortality shows that the maintenance of fluid
tients were included in this prospective multicenter cohort balance and the removal of small solutes deserve equal attention.
study. Cox proportional hazards regression was used to predict
mortality and technique failure.
Results. There were 33 deaths and 44 technique failures. The
Dialysis prolongs the life of patients with end-stagetwo-year patient survival was 77%, and the two-year technique
renal disease (ESRD) by the removal of excess watersurvival was 64%. Age, systolic blood pressure, and the abso-
lute quantity of small solutes removed at baseline were inde- and waste products. Despite this, mortality rates greatly
pendent predictors of mortality. A one-year increase in age exceed those in the general population [1]. Several stud-
was associated with a relative risk (RR) of death of 1.05 (95% ies have shown that comorbid conditions at the initiation
of dialysis treatment are important predictors of mortal-
ity, irrespective of the mode of dialysis therapy [2–5].1 The Netherlands Cooperative Study on the Adequacy of Dialysis
(NECOSAD) Study Group members are as follows: J. Barendregt Furthermore, studies in peritoneal dialysis (PD) patients
(Maastricht); M. Boekhout (Leiderdorp); E.W. Boeschoten, W.J.W.
have documented the importance of cardiovascular co-Bos, and H.R. Bu¨ller (Amsterdam); F.Th. de Charro (Rotterdam); F.W.
Dekker (Amsterdam); A. van Es (Hilversum); J.A.C.A. van Geelen morbidity and parameters of nutritional state to mortal-
(Alkmaar); W. Geerlings (‘s-Gravenhage); P.G.G. Gerlag (Veldhoven); ity [6–9]. In PD, technique survival is much lower than in
J.P.M.C. Gorgels (Haarlem); R.M. Huisman (Haren); K.J. Jager (Am-
hemodialysis (HD) [10–13]. Peritonitis remains an impor-sterdam); W.A.H. Koning-Mulder (Enschede); M.I. Koolen (‘s-Herto-
genbosch); R.T. Krediet (Amsterdam); K.M.L. Leunissen (Maastricht); tant cause for transfer from PD to HD [9, 13, 14]. The
R. van Leusen (Arnhem); M.P. Merkus (Amsterdam); K.J. Parlevliet risk of technique failure is higher in nondiabetics [12],
(Arnhem); C.H. Schro¨der (Utrecht); P. Stevens (Amsterdam); J.G.P.
in patients with a low serum albumin [9, 15], a low dietaryTijssen (Amsterdam); R.M. Valentijn (‘s-Gravenhage); H.H. Vincent
(Nieuwegein); P. Vos (Utrecht). protein intake [7], and a low creatinine clearance [7, 9].
Data on the role of age are contradictory [7, 12, 13].
Key words: dialysis technique failure, hypertension, systolic blood pres-
In analogy with HD, many investigators have triedsure, fluid overload, peritoneal ultrafiltration.
to define adequate PD by parameters of small solute
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an association between higher small solute clearancesAccepted for publication November 3, 1998
and better patient survival [9, 14, 16]. This finding has
resulted in the formulation of very strict minimum targets 1999 by the International Society of Nephrology
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for adequate PD in the United States, based on urea was recorded if one of the following conditions had been
and creatinine kinetics [17]. However, it has been sug- present: angina pectoris, myocardial infarction, class III
gested that too much emphasis has been put on the to IV congestive heart failure, or peripheral vascular
removal of small solutes while underestimating the im- disease. The comorbidity risk for patient survival was
portance of the maintenance of fluid balance [18]. This expressed as the Davies risk score [8].
is supported by the growing evidence that high peritoneal Systolic and diastolic blood pressures and heart rate
transport of creatinine is independently associated with were measured once at a routine visit in the outpatient
lower patient survival, probably by the mechanism of clinic. Mean arterial blood pressure was calculated as dia-
ultrafiltration failure [14, 19–22]. However, neither the stolic blood pressure 1 1/3 (systolic blood pressure minus
CANUSA study [9] nor the studies of Maiorca et al [16] diastolic blood pressure), and pulse pressure as systolic
and Davies, Phillips and Russell [14] assessed manifesta- blood pressure minus diastolic blood pressure. A blood
tions of fluid overload as potential risk factors for patient laboratory investigation included hemoglobin, serum al-
survival. bumin, plasma urea, and plasma creatinine. Nutritional
In the Netherlands Cooperative Study on the Ade- status was assessed by the body mass index, the percent-
quacy of Dialysis (NECOSAD), an ongoing prospective age of lean body mass, serum albumin, and an estimation
multicenter cohort study in new ESRD patients starting of dietary protein intake. The percentage of lean body
dialysis treatment, we collected data on both solute re- mass was determined by measurement of skinfold thick-
moval and on blood pressure as an indicator of fluid over- ness at four sites (biceps, triceps, subscapular, and iliac)
load. The aim of this study was to determine the relative [23]. These measurements were performed by trained
importance of baseline patient and treatment character- nurses and dietitians. Serum albumin was determined by
istics to mortality and technique failure in PD patients. the method routinely used in the centers: bromcresol
green (N 5 5), bromcresol purple (N 5 7), or an immuno-
logic method (N 5 1). The dietary protein intake wasMETHODS
estimated as protein nitrogen appearance [PNA (g/24Patients and follow-up period
hr) 5 19 1 0.2134 3 urea appearance (mmol/24 hr)]
End-stage renal disease patients who were older than [24], normalized to actual body weight (nPNA). Subse-
18 years when starting chronic PD, who had never re- quently, anthropometric parameters and serum albumin
ceived renal replacement therapy in the past, and who were combined to a malnutrition index, corrected for
had survived the first three months on dialysis were eligi- age, sex, height, and frame size, similar to the index
ble for the study. From 13 Dutch dialysis centers, we described by Harty et al [25], but without the use of the
included consecutive patients who started PD between
subjective global assessment. A score of 11 or higher
October 1, 1993, and April 1, 1995, after their informed
was defined as severe malnutrition.consent was obtained. The measurement at three months
A 24-hour urine collection was used to determine dailyafter initiation of dialysis was taken as baseline. This
urine volume and to calculate residual glomerular filtra-patient cohort was followed until July 1, 1997. Data on
tion rate, renal Kt/V urea, renal creatinine clearance, andmortality and dialysis technique were obtained from the
the urinary urea and creatinine appearance. Residualmedical records by instructed nurses in the dialysis cen-
glomerular filtration rate was defined as the mean of theters. The causes of death were classified according to the
urea and creatinine clearances. Peritoneal solute re-codes of the European Dialysis and Transplant Asso-
moval and ultrafiltration were assessed from a 24-hourciation-European Renal Association Registry by the
dialysate collection.nephrologist taking care of the patient. At the study
Total removal of waste products (renal plus peritonealcoordinating center, these data were checked for com-
removal) was measured as clearance estimated by totalpleteness using the database of RENINE, the Renal
weekly Kt/V urea (/week), total weekly creatinine clear-Replacement Registry in the Netherlands.
ance (liter/week/1.73 m2), and as absolute mass removal
Data collection at baseline estimated by total weekly urea and creatinine appear-
ance (mmol/week/1.73 m2). The urea distribution volumeData were collected on demography, primary renal
(V) was determined by the formulae of Watson et aldisease, comorbidity, laboratory investigations, blood
for total body water [26]. The dialysate/plasma ratio ofpressure, nutritional status, renal function, therapy char-
creatinine (D/P creatinine) was calculated from the con-acteristics, such as small solute removal, fluid removal,
centrations of creatinine in the 24-hour dialysate andand medication, and on quality of life. Primary renal
the plasma. Patients were classified as high transportersdisease was classified according to the codes of the Euro-
when D/P creatinine was higher than the mean valuepean Dialysis and Transplant Association-European Re-
plus one standard deviation [27]. Total fluid removal wasnal Association Registry. Comorbid conditions present
at the start of dialysis were scored. Cardiovascular disease estimated as urine volume plus peritoneal ultrafiltration.
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Table 1. Demographic and clinical factors at baseline (3 monthsData on medication were collected from the medical
after the start of dialysis)
records.
FactorQuality of life was determined by the Karnofsky index
Age years 54 (14)[28] and was scored by a physician or a nurse and by
Gender % male 64the 36-Item Short Form Health Survey Questionnaire
Primary renal disease %
(SF-36) [29, 30], which was completed by the patients. Hypertension/renal vascular disease 23
Diabetes mellitus 16The eight scales of the SF-36 reflecting physical function-
Comorbidity %ing, well being, and general health concepts were com-
Diabetes mellitus 20
bined into a physical and a mental component summary Cardiovascular disease 25
Davies risk scorescore. Higher scores in these instruments indicate a bet-
Grade I (no comorbidity) 52ter quality of life.
Grade II (intermediate comorbidity) 41
Grade III (severe comorbidity) 7
Analytical methods Blood pressure mm Hg
Systolic 142 (22)Statistical analysis of patient and technique survival
Diastolic 85 (11)
was performed by the Cox proportional hazards model. Mean 104 (13)
Pulse 57 (19)With this technique, groups of patients can be compared
Heart rate /min 80 (13)while adjusting for differences in other characteristics.
Medication %
The influence of a baseline characteristic on the occur- Antihypertensive agents 66
Erythropoietin 67rence of an event was expressed in terms of the relative
Quality of liferisk (RR), calculated as the hazard ratio from the Cox
Karnofsky index 80 (16)
proportional hazards model. In the analysis of patient Short form-36 physical component summary score 40.0 (8.7)
Short form-36 mental component summary score 46.4 (9.8)survival, the event was death, whereas transplantation
was a censored observation. Patients alive and on dialysis Values are presented as % or means (sd).
on July 1, 1997 were censored at that date. For the analy-
sis of technique survival, transfer to HD was the event,
and censored observations were patient death and trans-
kerke’s R2, which was calculated on the basis of the SPSSplantation. Patients alive and on PD on July 1, 1997 were
values for 22 log likelihood ratios.censored at that date.
The likelihood ratio test was used to determine whether
the addition of a variable to a model added significantly RESULTS
to that model. Variables significant at a P value less
Patients and baseline characteristicsthan 0.20 in univariate regression were presented to the
One hundred and eighteen patients were included.model, and only variables significant at a P value of less
One hundred and twelve of them were on continuousthan 0.05 were kept in the model. Initially, demographic
ambulatory PD (CAPD), and the remaining six werevariables, primary renal disease, and different parame-
on other forms of PD. The mean and median instilledters of comorbidity were presented to the model by for-
dialysate volumes on CAPD were 7.4 and 8.0 liters perward selection. Thereafter, parameters of residual renal
24 hours, with a mean glucose concentration of 2.15%.function, hemodynamics, nutritional status, and labora-
Data on demography, primary renal disease, comorbid-tory blood investigations were presented to the model,
ity, hemodynamics, medication, and quality of life arefollowed by therapy characteristics such as adequacy pa-
shown in Table 1. The baseline values for nutritionalrameters and antihypertensive medication. Separate
status and adequacy are shown in Table 2. Forty-ninemodels were built for urea and creatinine removal. Fi-
percent of the patients had a total Kt/V urea of less thannally, parameters of quality of life were presented to the
2.0 per week, and 26% had a total creatinine clearancemodels that contained all of the significant demographic
less than 60 liter/week/1.73 m2. The contribution of theand clinical variables and therapy characteristics. This
residual renal function to the overall creatinine clearanceprocedure was repeated with a backward selection strat-
was almost 50%.egy. Subsequently, the results of both strategies were
compared. To estimate how well the final model pre-
Eventsdicted patient survival, Nagelkerke’s R2 was used [31].
The total follow-up period was 247 patient years afterThis parameter provides an estimate of the percentage
start of dialysis, with a mean of 25 months (range 4 toof explained variance, but it does not adjust for the
44 months). Thirty-three patients died. Causes of deathnumber of variables used in the model. All analyses were
were classified as cardiovascular or cerebrovascular (N 5performed with SAS for Windows 6.10 (SAS Institute
11), infection (N 5 8), malignancy (N 5 2), withdrawalInc., Cary, NC, USA) and SPSS for Windows 6.1.3 (SPSS
Inc., Chicago, IL, USA), with the exception of Nagel- from dialysis because the patient refused further treat-
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Table 2. Nutritional status and adequacy at baseline
Factor
Hemoglobin g/dl 11.4 (1.5)
Serum albumin g/liter 36.0 (6.0)
Plasma urea mmol /liter 23.1 (7.0)
Plasma creatinine lmol /liter 804 (215)
nPNA g/kg/24 hr 1.1 (0.3)
Lean body mass % 76.9 (8.0)
Body weight kg 68.5 (13.0)
Body mass index kg/m2 23.1 (3.5)
Severe malnutrition % 19.3
Residual GFR ml/min 3.1 (2.4)
Kt/V urea week
Total 2.1 (0.5)
Renal 0.6 (0.4)
Creatinine clearance liter/week /1.73 m2
Total 83 (29)
Renal 40 (30)
Urea appearance mmol /week /1.73 m2 Fig. 1. Kaplan-Meier curves for the probability of patient survival (up-
Total 1671 (578) per line), stay on dialysis (middle line), and stay on peritoneal dialysis
Urine 445 (380) (bottom line). Death is the event in the patient survival curve, whereas
Creatinine appearance mmol /week /1.73 m2 transplantation is a censored observation. Death and transplantation
Total 64.3 (19.2) are the events in the stay on dialysis curve. Death, transplantation, and
Urine 29.1 (20.3) transfer to hemodialysis are all events in the stay on peritoneal dialysis
D/P creatinine 0.77 (0.14) curve.
High transport status % 11.9
Fluid removal ml/24 hr
Total 1547 (912)
Urine 771 (698)
the Karnofsky index, and the SF-36 physical componentValues are presented as % or means (sd).
summary score. The final Cox proportional hazards mod-
els for patient survival obtained by forward and back-
ward selection were identical. They showed that age,
ment (N 5 4), and as various other causes (N 5 8). systolic blood pressure, and small solute appearance
Forty-six patients received a kidney transplant. During were all significant predictors of death. Table 4 shows
the follow-up period, 44 patients were transferred to the model containing total creatinine appearance as ade-
HD, 39 of them for medical reasons, in more than half quacy parameter. Similar results were obtained when
of the cases because of peritonitis. One patient was trans- total urea appearance was used instead [RR 5 0.89 (95%
ferred for social reasons, and one patient preferred HD. CI, 0.81 to 0.97) per 100 mmol/week/1.73 m2]. Table 5
In three patients, the reasons for technique change were shows that both urinary and dialysate creatinine appear-
unknown. On July 1, 1997, 39 patients were alive, 19 of ance were independent predictors of patient survival.
them were treated by HD and 20 by PD. Again, similar results were obtained when urinary and
dialysate urea appearance were used, although the latter
Mortality did not reach statistical significance [RR 5 0.86 (95%
Patient survival, the stay on dialysis, and the stay on CI, 0.74 to 1.00) and RR 5 0.91 (95% CI, 0.80 to 1.02)
PD are shown in Figure 1. Two-year patient survival was per 100 mmol/week/1.73 m2]. Analogous to this, similar
77%, and three-year patient survival was 64%. The RRs results were obtained when pulse pressure was used in-
of death associated with the patient and therapy charac- stead of systolic blood pressure [RR 5 1.43 (95% CI,
teristics are shown in Table 3. Because of the small num- 1.15 to 1.78) per 10 mm Hg]. There were only small
ber of patients in the subgroup with severe comorbidity differences in the percentage of explained variance be-
(Davies risk score), the subgroups of patients with inter- tween these models, but the model shown in Table 5
mediate and severe comorbidity were combined. The was the best one, explaining 32% of the variance in
following variables reached statistical significance at a P mortality.
value of 0.20 in univariate relations and were presented The addition of parameters reflecting clearance, such
to the Cox model: age, primary renal disease, cardiovas- as total Kt/V urea or total creatinine clearance, to a
cular disease, comorbidity, residual glomerular filtration model containing age and systolic blood pressure re-
rate, urinary urea, and creatinine appearance, systolic sulted in RRs of less than 1.00, but without reaching
blood pressure, mean arterial pressure, pulse pressure, statistical significance [RR 5 0.94 (95% CI, 0.85 to 1.03)
heart rate, nPNA, serum albumin, plasma urea and creat- per 0.1/week and RR 5 0.95 (95% CI, 0.87 to 1.03) per
inine, total Kt/V urea, total and dialysate urea and creati- 5 liter/week/1.73 m2]. In multivariate analysis, systolic
blood pressure was not associated with mortality whennine appearance, the use of antihypertensive medication,
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Table 3. Mortality and relative risk of death of baseline characteristics in univariate Cox regression
Mortality Relative 95% Confidence
Factor % risk interval
Demographics and comorbidity
Age 1 year a,c 1.06 1.02–1.09
Gender
Female 26 0.88 0.43–1.83
Male 29 reference —
Primary renal diseasea
Diabetes mellitus 42 7.61 0.95–60.86
Hypertension/renal vascular disease 33 6.99 0.88–55.19
Glomerulonephritis 5 reference —
Other 28 5.64 0.74–42.76
Diabetes mellitus
Present 42 1.60 0.76–3.36
Absent 25 reference —
Cardiovascular diseasea
Present 47 2.00 1.00–4.00
Absent 22 reference —
Davies risk scorea
Grade I 18 reference —
Grade II/III 39 2.15 1.04–4.43
Renal function
Residual GFR 1 ml /mina 0.90 0.76–1.06
Renal Kt/V urea 0.1/week 0.96 0.88–1.05
Renal creatinine clearance 5 liter/week /1.73 m2 0.97 0.91–1.03
Urinary urea appearance 100 mmol /week /1.73 m2a 0.89 0.79–1.01
Urinary creatinine appearance 1 mmol /week /1.73 m2a 0.98 0.96–1.00
Urine volume ml/24 hr
0 44 reference —
.0 and ,1000 28 0.57 0.20–1.66
$1000 23 0.50 0.15–1.72
Hemodynamics
Systolic blood pressure 10 mm Hga,b 1.25 1.09–1.45
Diastolic blood pressure 10 mm Hg 0.89 0.66–1.21
Mean blood pressure 10 mm Hga 1.18 0.92–1.51
Pulse pressure 10 mm Hga,c 1.33 1.16–1.54
Heart rate 1/mina 1.03 1.00–1.05
Nutritional status
Body mass index 1 kg/m2 1.01 0.91–1.11
nPNA 0.1 g/kg/24 hr a,b 0.77 0.64–0.92
Lean body mass 1% 0.98 0.94–1.02
Severe malnutrition
Present 24 0.79 0.30–2.09
Absent 26 reference —
Laboratory blood investigations
Serum albumin 1 g/liter a 0.94 0.89–0.99
Hemoglobin 1 g/dl 0.99 0.80–1.24
Plasma urea 1 mmol /liter a,b 0.93 0.88–0.98
Plasma creatinine 100 lmol /liter a 0.86 0.74–1.01
Therapy
Kt/V urea 0.1/week
Totala 0.93 0.85–1.02
Peritoneal 0.95 0.84–1.08
Creatinine clearance 5 liter/week /1.73 m2
Total 0.96 0.89–1.03
Peritoneal 0.96 0.81–1.13
Urea appearance 100 mmol /week /1.73 m2
Totala,b 0.88 0.81–0.96
Dialysatea 0.88 0.79–0.97
Creatinine appearance 1 mmol /week /1.73 m2
Totala,b 0.96 0.94–0.99
Dialysatea 0.96 0.93–1.00
High peritoneal transport status
Present 43 1.55 0.64–3.77
Absent 26 reference —
Fluid removal 500 ml /24 hr
Total 1.02 0.85–1.22
Peritoneal ultrafiltration 1.05 0.86–1.27
Antihypertensive medicationa
Yes 23 0.57 0.28–1.12
No 38 reference —
(continued)
Jager et al: Survival in peritoneal dialysis 1481
Table 3. Continued
Mortality Relative 95% Confidence
Factor % risk interval
Erythropoietin use
Yes 30 1.25 0.58–2.69
No 23 reference —
Quality of life
Karnofsky indexa
90–100 18 reference —
70–80 33 1.56 0.70–3.47
,70 50 2.38 0.93–6.09
Short form-36 physical component summary score (1 point)a 0.94 0.89–0.99
Short form-36 mental component summary score (1 point) 1.02 0.98–1.06
a The relative risks of these parameters had a P , 0.20 in univariate analysis and were subsequently presented to the Cox model (results in Tables 4 and 5)
b P , 0.01
c P , 0.001
Table 4. Multivariate Cox proportional hazards model for patient
survival using total creatinine appearance
Relative 95% Confidence
Factor risk interval
Age 1 year a 1.06 1.02–1.10
Systolic blood pressure
10 mm Hgb 1.42 1.17–1.73
Total creatinine appearance
1 mmol /week /1.73 m2 a 0.95 0.92–0.98
a P , 0.01; b P , 0.001
Table 5. Multivariate Cox proportional hazards model for patient
survival using urinary and dialysate creatinine appearance
Relative 95% Confidence
Factor risk interval
Age 1 year 1.05 1.01–1.09
Systolic blood pressure
Fig. 2. Kaplan-Meier curve for the probability of technique survival.10 mm Hga 1.42 1.17–1.73
Transfer to hemodialysis is the event; death and transplantation areUrinary creatinine appearance
censored observations.1 mmol /week /1.73 m2 b 0.95 0.92–0.98
Dialysate creatinine appearance
1 mmol /week /1.73 m2 b 0.93 0.89–0.98
a P , 0.001; b P , 0.01
fluid removal was the only significant predictor of tech-
nique failure [RR 5 0.79 (95% CI, 0.68 to 0.93) per 500
ml per 24 hr]. Backward selection resulted in a Cox
ESRD was caused by hypertension or renal vascular model with systolic blood pressure [RR 5 1.22 (95% CI,
disease [RR 5 1.10 (95% CI, 0.75 to 1.61) per 10 mm Hg]. 1.05 to 1.41) per 10 mm Hg], urine volume [.0 and
Conversely, when it was caused by diabetes, the effect ,1000 ml/24 hr, RR 5 0.49 (95% CI, 0.19 to 1.31);
of systolic blood pressure was more pronounced [RR 5 $1000 ml/24 hr, RR 5 0.13 (95% CI, 0.04 to 0.48)], and
2.54 (95% CI, 1.10 to 5.87) per 10 mm Hg]. In patients peritoneal ultrafiltration [RR 5 0.73 (95% CI, 0.61 to
of 65 years of age and older (N 5 30), age did not predict 0.87) per 500 ml/24 hr]. These three variables explained
survival [RR 5 1.02 (95% CI, 0.89 to 1.18) per year]. 16% of the variance in technique failure.
The RRs of systolic blood pressure and creatinine ap-
pearance in this group were similar to those found in
DISCUSSIONthe total study population.
Using a Cox proportional hazards model, we prospec-
Technique failure tively studied the effect of baseline covariates such as
patient and treatment characteristics on patient and tech-Two-year technique survival was 64%, and the three-
year technique survival was 53% (Fig. 2). In multivariate nique survival in a cohort of 118 new PD patients. Age,
systolic blood pressure, and urinary as well as dialysateCox regression using a forward selection strategy, total
Jager et al: Survival in peritoneal dialysis1482
creatinine appearance at three months after the start of did not reach statistical significance. These findings make
a case for the use of absolute mass removal parametersdialysis were independent predictors of patient survival.
These four parameters explained the variance in mortal- as markers of adequacy instead of clearance parameters,
provided plasma urea and creatinine are not extremelyity for 32%.
In the general population, high blood pressure is a high. Such an approach has been suggested previously
[55–57]. The clearance concept, relating the solute massrisk factor for cardiovascular morbidity and mortality.
Several studies have shown a relationship with stroke transported across the membrane to the plasma concen-
tration, has been developed to characterize the quality[32–34], coronary heart disease [33–35], and cardiovascu-
lar death [34, 36]. In the older population, the risk of of a membrane, but not to estimate the removal of waste
products. Creatinine appearance depends on both mus-complications of cardiovascular disease is dominated by
the systolic blood pressure [37]. Recent studies have cle mass and creatinine transport. In the CANUSA
study, creatinine appearance was used to calculate leanshown that borderline isolated systolic hypertension [34]
and high pulse pressure [38] are also associated with body mass [9, 58]. Every percent of decrease in lean
body mass, indicated by a lower creatinine appearance,an elevated risk of cardiovascular death. Furthermore,
treatment of isolated systolic hypertension reduces car- was associated with a 3% increase in the risk of death.
We chose not to use the percentage of lean body massdiovascular morbidity and mortality [39, 40]. In PD pa-
tients, Foley et al have shown a relationship between calculated by creatinine appearance as a parameter of
nutritional status because a number of patients in ourmean arterial blood pressure and cardiovascular morbid-
ity, but they could not establish an association between study population had values of more than 100%. More-
over, lean body mass calculated by anthropometry wasmean arterial blood pressure and death [41]. However,
data from our study and from other studies [4, 42] did not associated with patient survival, neither in univariate
nor multivariate analysis. The results of our study clearlyshow a relationship between hypertension and death.
The data from our study and that of Kemperman et al indicate that small solute removal by dialysis and small
solute removal by residual renal function are both associ-also suggest that the effect of blood pressure on survival
is primarily mediated by the systolic pressure, as has ated with a lower risk of death. A reduction in the risk of
death by dialysis, separate from the influence of residualbeen suggested for the elderly in the general population
[37, 42]. The prevalence of systolic hypertension in renal function, could neither be shown for peritoneal
Kt/V urea or peritoneal creatinine clearance in a recentESRD patients is high [43]. In these patients, two specific
causes of systolic hypertension are often present: in- reanalysis of the CANUSA data [abstract; Bargman JM,
Perit Dial Int 18(Suppl 1):S12, 1998] nor for peritonealcreased arterial stiffness and fluid overload [44–46]. Ar-
terial stiffness increases pulse wave velocity, thereby Kt/Vurea in a recently published study by Davies, Phil-
lips and Russell [14].causing early wave reflections. Consequently, reflected
pressure waves reach the ascending aorta during systole Previous studies have found that comorbid conditions
[2, 4–9], serum albumin concentration [2, 4, 6, 9], andinstead of during diastole, which results in elevated sys-
tolic and decreased diastolic blood pressure [47, 48]. parameters of nutritional status [6, 7, 9] were all indepen-
dent predictors of survival in PD patients. We have notFluid overload, a condition often present in PD patients
[49, 50], causes an elevation of the systolic blood pressure been able to confirm these results, which is possibly due
to a lack of statistical power. Relatively small studies,and to a lesser extent also of the diastolic blood pressure
[51]. In this study, it is not possible to distinguish between such as this one, may obtain nonsignificant results,
whereas, in reality, a weak relationship does exist (typearterial stiffness and fluid overload as the cause of systolic
hypertension. However, high systolic blood pressure may II statistical error). However, despite this limited number
of patients, we were able to detect clinically relevantaccelerate large artery stiffness and thus perpetuate a
vicious cycle [52]. A rise in systolic pressure increases prognostic factors. An additional explanation for the
lack of statistical significance of known prognostic factorsthe left ventricular afterload as well as the oxygen de-
mand [47, 48] and is related to left ventricular hypertro- in the multivariate Cox model in our study may also be
the fact that age, systolic blood pressure, and small solutephy [53]. The latter condition is a predictor of mortality
in ESRD patients [2, 54]. A reduction of the systolic blood removal partly explain their variance. Potential causes
in the case of specific parameters are discussed in thepressure, by pharmacological therapy or by the active
treatment of fluid overload, may therefore be an impor- following paragraphs.
In our study, comorbidity risk was expressed by thetant approach to reduce the risk of death in PD patients.
Of the parameters representing small solute removal, Davies risk score, which takes into account both the
presence and the type of comorbid conditions. Comor-both creatinine and urea appearance were independent
predictors of death, but creatinine appearance was bidity risk in relation to mortality may, however, be
better expressed by an index that also considers the se-slightly more powerful. However, the relative mortality
risks associated with Kt/V urea and creatinine clearance verity of comorbid conditions. The development of such
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